Cancro da próstata com tratamento inovador

Referências

National Cancer Institute. Dictionary of Cancer Terms – Androgen. Available at: http://www.cancer.gov/dictionary?CdrID=45592.
American Cancer Society. Cancer Facts & Figures 2010. Atlanta: American Cancer Society; 2010.
ZYTIGA (abiraterone acetate) Draft Label. November 2010.
ZYTIGA (abiraterone acetate) Draft Label. November 2010.
Bono JS, Logothetis CJ, et al. Survival In Metastatic Prostate Cancer Treated with Abiraterone Acetate. New England Journal of Medicine. N Engl J Med 2011; 364:1995-2005 May 26, 2011
Hotte SJ, Saad F. Current management of castrate-resistant prostate cancer. Curr Oncol. 2010 September; 17(Supplement 2): S72-S79.
An Introduction to Prostate Cancer. Prostate Cancer Foundation. 2009. Available at: http://www.prostatecancerfoundation.org/atf/cf/{705B3273-F2EF-4EF6-A653-E15C5D8BB6B1}/IntroProstateCancer.pdf. Accessed November 2009.
Mayo Clinic. “Prostate Cancer.” http://www.mayoclinic.com/health/prostate-cancer/DS00043. Accessed September 10, 2010.
LOBOCAN 2008 (IARC). “Prostate Cancer.” http://globocan.iarc.fr/factsheets/cancers/prostate.asp. Accessed August 1, 2010.
GLOBOCAN 2008 (IARC). “Prostate Cancer.” http://globocan.iarc.fr/factsheets/cancers/prostate.asp. Accessed August 1, 2010.
GLOBOCAN 2008 (IARC). “Prostate Cancer.” http://globocan.iarc.fr/factsheets/cancers/prostate.asp. Accessed August 1, 2010.
Parkin, D. et al. “Global Cancer Statistics 2002.” CA Cancer J Clin (2005) 55;74-108.

LPM Comunicação

www.lpmcom.pt